rs983417935
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP2BP4
The NM_001184880.2(PCDH19):c.2125G>C(p.Glu709Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000268 in 112,034 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 9Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PCDH19 | NM_001184880.2 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 6 | ENST00000373034.8 | NP_001171809.1 | |
| PCDH19 | NM_001105243.2 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 5 | NP_001098713.1 | ||
| PCDH19 | NM_020766.3 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 5 | NP_065817.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | ENST00000373034.8 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
| PCDH19 | ENST00000255531.8 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 5 | 1 | ENSP00000255531.7 | |||
| PCDH19 | ENST00000420881.6 | c.2125G>C | p.Glu709Gln | missense_variant | Exon 1 of 5 | 1 | ENSP00000400327.2 | |||
| PCDH19 | ENST00000636150.1 | c.43G>C | p.Glu15Gln | missense_variant | Exon 1 of 3 | 5 | ENSP00000490463.1 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112034Hom.: 0 Cov.: 24 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 9.15e-7 AC: 1AN: 1092569Hom.: 0 Cov.: 30 AF XY: 0.00000279 AC XY: 1AN XY: 358809 show subpopulations
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112034Hom.: 0 Cov.: 24 AF XY: 0.0000292 AC XY: 1AN XY: 34198 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 709 of the PCDH19 protein (p.Glu709Gln). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 533848). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PCDH19 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at